Skip to main content
. 2021 Apr 1;11:582676. doi: 10.3389/fonc.2021.582676

Table 4.

Multivariate analyses of prognostic factors for PFS.

Prognosticators P-value
Performance status 0.371
LDH 0.107
Liver metastases 0.533
Regimen 0.166
TrHE 0.014

LDH, lactate dehydrogenase; Regimen, including BRAFi, BRAFi+MEKi and BRAFi+anti-PD-1 antibody; trHE, treatment-related hepatotoxicity defined as the increase of either ALT, AST or bilirubin levels.